Biogen (NASDAQ: BIIB) awards 8,025 restricted stock units to HR EVP

Rhea-AI Filing Summary

Gregory Ginger reported acquisition or exercise transactions in this Form 4 filing.

BIOGEN INC. executive Gregory Ginger, EVP of Human Resources, received an equity grant of 8,025 restricted stock units on February 13, 2026. These RSUs were awarded at no cash cost to him as part of his compensation and represent a right to receive Biogen shares in the future.

The 8,025 restricted stock units vest in three equal yearly installments, beginning on the first anniversary of the February 13, 2026 grant date. All units are reported as directly owned following the grant, meaning his reported derivative holdings increased by the full award amount.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gregory Ginger

Role EVP, Human Resources

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	8,025	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 8,025 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gregory Ginger

(Last) (First) (Middle)

BIOGEN INC.

225 BINNEY ST.

(Street)

CAMBRIDGE MA 02142

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BIOGEN INC. [ BIIB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Human Resources

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0	02/13/2026		A		8,025		(1)	02/13/2029	Common Stock	8,025	$0	8,025	D

Explanation of Responses:

1. The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.

	/s/ Wendell Taylor, attorney in fact for Ginger Gregory	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Biogen (BIIB) report for Gregory Ginger?

Biogen reported that EVP of Human Resources Gregory Ginger received a grant of 8,025 restricted stock units. The award was given at no cash cost per unit and is part of his equity compensation, increasing his directly held derivative position to 8,025 RSUs.

How many restricted stock units did Biogen (BIIB) grant to its HR EVP?

Biogen granted 8,025 restricted stock units to its EVP of Human Resources, Gregory Ginger. These RSUs were awarded on February 13, 2026 and will vest over time, aligning his compensation with the company’s long-term performance through equity-based incentives.

What is the vesting schedule of Gregory Ginger’s Biogen (BIIB) RSU grant?

The 8,025 restricted stock units granted to Gregory Ginger vest in three equal yearly installments. Vesting begins on the first anniversary of the February 13, 2026 grant date, meaning one-third of the units will vest each year over a three-year period.

Did Gregory Ginger buy or sell any Biogen (BIIB) shares in this Form 4?

The Form 4 shows an acquisition through a grant of 8,025 restricted stock units, not an open-market buy or sale. The transaction is coded as a grant, award, or other acquisition, reflecting equity compensation rather than a cash purchase or sale of shares.

How did this RSU grant change Gregory Ginger’s Biogen (BIIB) holdings?

Following the grant, Gregory Ginger’s directly reported derivative holdings increased to 8,025 restricted stock units. All of these units come from the February 13, 2026 award, and will convert into shares only as they vest according to the disclosed three-year schedule.